Pharmaceutical Industry Information Portal

HomeNews

News

Remdeform is included into all COVID-19 treatment regimens

Remdesivir (trade name: Remdeform, MA No. ЛП-006505 of October 14, 2020г) has been included into all in-hospital treatment regimens in the 12th version of...

Areplivir developed by Promomed for the treatment of coronavirus infection received marketing authorization in Uzbekistan

Areplivir, included in the guidelines of the Ministry of Health of Russia for the treatment of COVID-19, received marketing authorization in Uzbekistan. On August 4,...

Pharmstandard-UfaVITA: Investments in the Modernisation of Production

According to the press service of the Government of the Republic of Bashkortostan, Bashkiria quadrupled its production of medicines in July this year. The...

Honorary guests of the Tyumen Oil and Gas Forum visited the hormonal plant of Pharmasyntez-Tyumen prepared for launch

On September 15, the Pharmasyntez-Tyumen hormonal plant under construction in Tyumen was visited by Yuri Borisov, Deputy Prime Minister of the Russian Federation, Vladimir...

IDTM International Journal publishes first data on the use of Polyoxidonium as preventive medicine against COVID-19

The experience of using the Russian original medication Polyoxidonium (azoximer bromide) for preventive purposes among the personnel of the "Red Zone" described by the...

Binnopharm Group invests RUB 2.5 bn in a state-of-the-art R&D hub

Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, has announced plans to unite all its research divisions into a cutting-edge R&D hub...
spot_img

Expert Articles

spot_img